NEFL and Alzheimer disease: Our ROC-derived plasma NfL cutoff was 36.5 pg/mL, which has specificity of 90% (i.e., similar to the amyloid-negative control cutoffs in Ashton et al. [1]) and sensitivity of 42% for Braak stage VI AD.